At some point MANF to the eye is - AMBS Amarantus Bioscience Holdings

Home
Mailbox
Boards
Favorites
Whats Hot!
Login - Join Now!

Search Search Type

Amarantus Bioscience Holdi AMBS

(Total Views: 269)

Posted On: 09/19/2023 8:36:07 AM

Post# of 30034

Posted By: freegriff

At some point MANF to the eye is a minimal risk, must have investment. This is great news for the entire field of gene therapy for Opthalmology and great news for patients with Wolfeams, RAO, RP etc

https://www.bbc.com/news/science-environment-36101786.amp